Insider: Welgus Howard G. Director - Arcutis Biotherapeutics, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 49,744 | 0 | 49,744 |
| Value | $1,198,830.40 | $0.00 | $1,198,830.40 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 03/02/2026 | DDS | 10,000 | Direct | COM | $25.65 | $256,518.00 | 49,744 |
| 02/02/2026 | DDS | 10,000 | Direct | COM | $25.05 | $250,483.00 | 59,744 |
| 01/02/2026 | DDS | 10,000 | Direct | COM | $28.96 | $289,606.00 | 69,744 |
| 12/01/2025 | DDS | 10,000 | Direct | COM | $30.21 | $302,133.00 | 79,744 |
| 11/03/2025 | DDS | 10,000 | Direct | COM | $25.27 | $252,669.00 | 89,744 |
| 10/01/2025 | DDS | 9,538 | Direct | COM | $18.92 | $180,484.71 | 100,206 |
| 10/01/2025 | DDS | 462 | Direct | COM | $18.92 | $8,742.29 | 99,744 |
| 09/02/2025 | DDS | 10,000 | Direct | COM | $15.64 | $156,383.00 | 100,206 |
| 08/01/2025 | DDS | 3,890 | Direct | COM | $14.30 | $55,620.00 | 100,206 |
| 08/01/2025 | DDS | 6,110 | Direct | COM | $14.30 | $87,362.00 | 100,206 |
| 07/01/2025 | DDS | 9,208 | Direct | COM | $13.84 | $127,430.43 | 100,206 |
| 06/18/2025 | DDS | 10,139 | Direct | COM | $13.37 | $135,573.64 | 109,414 |
| 05/01/2025 | DDS | 10,000 | Direct | COM | $14.64 | $146,357.00 | 111,944 |
| 04/01/2025 | DDS | 10,000 | Direct | COM | $15.12 | $151,236.00 | 121,944 |
| 03/03/2025 | DDS | 10,000 | Direct | COM | $13.00 | $130,048.00 | 131,944 |
| 02/03/2025 | DDS | 10,000 | Direct | COM | $12.71 | $127,100.00 | 141,944 |
| 01/02/2025 | DDS | 10,000 | Direct | COM | $14.67 | $146,714.00 | 151,944 |
| 12/02/2024 | DDS | 10,000 | Direct | COM | $12.51 | $125,133.00 | 161,944 |
| 11/01/2024 | DDS | 10,000 | Direct | COM | $8.65 | $86,541.00 | 171,944 |
| 10/01/2024 | DDS | 10,000 | Direct | COM | $9.26 | $92,616.00 | 181,944 |
| 09/03/2024 | DDS | 10,000 | Direct | COM | $10.77 | $107,695.00 | 191,944 |
| 08/01/2024 | DDS | 6,614 | Direct | COM | $9.87 | $65,277.53 | 180,339 |
| 08/01/2024 | DDS | 3,386 | Direct | COM | $9.87 | $33,418.47 | 176,953 |
| 06/04/2024 | DDS | 3,542 | Direct | COM | $8.00 | $28,336.00 | 176,658 |
| 06/04/2024 | DDS | 6,458 | Direct | COM | $8.01 | $51,755.70 | 170,200 |
| 1 2 3 Next Last You are at page 1 of 3 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research